This course is part of PrimaryCareNOW: Live on December 10-12, 2025.
Woman reaching over her shoulder to ease pain in her back

Virtual CME Program

2.50 CME/CE Credit

Pain Management in Practice: Key Principles for Primary Care Providers

Primary Care Clinicians are at the front line of two powerful health challenges—managing pain responsibly while confronting the realities of opioid misuse and dependence.
Pri-Med’s Pain Management in Practice: Key Principals for PCPs delivers a dynamic, forward-thinking curriculum designed to help clinicians confidently navigate this evolving space. Clinicians will explore the newest insights in pain management, from innovative non-opioid therapies and multimodal treatment approaches to practical tools for identifying, managing, and tapering opioids safely.

Built around real-world cases, expert guidance, and evidence-based strategies, this program equips clinicians with the knowledge and skills to relieve pain, reduce risk, and elevate the quality of care for every patient.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies.
This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Register

CME/CE Information

2.50 AMA PRA Category 1 Credits™, 2.50 ABIM MOC or 2.50 AANP

Release Date: 12/10/2025

Expiration Date: 12/10/2025

Topics

Faculty

Learning Objectives

  • Define key concepts, mechanisms, and classifications of pain to enhance clinical understanding
  • Assess pain effectively while identifying risk factors for nonmedical use of opioids and substance/opioid use disorders
  • Evaluate evidence-based nonpharmacologic and nonopioid approaches to pain management
  • Review the role of opioids in pain management, including indications, limitations, and considerations for safe use
  • Safely initiate, adjust, and discontinue opioid therapy in patients with acute or chronic pain
  • Counsel patients on the safe use, storage, and disposal of opioid analgesics, including overdose reversal agents
  • Create personalized pain management plans integrating both opioid and nonopioid therapies
  • Diagnose and manage opioid use disorder, using evidence-based approaches, including referrals to specialists when needed"
     

Faculty

Charles E. Argoff, MD, FABPM

Vice Chair, Albany Medical College, Professor of Neurology and Urology

Director, Comprehensive Pain Center, Albany Medical Center, Director, Pain Management Fellowship, Albany, New York

Learn More

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, School of Medicine and Biomedical Sciences, University of Buffalo School of Medicine

Chief, Division of Pain Medicine, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Learn More

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chairperson, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Learn More

Disclosures

The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All have been mitigated by Pri-Med Institute:

Charles Argoff, MD, FABPM:  Speaker for Averitas Pharma, AbbVie, Lilly, Lundbeck, Impel Pharmaceuticals, Kowa Pharmaceuticals, Nevro Corporation, Scilex Pharmaceuticals, Teva Pharmaceuticals; Researcher for AbbVie; Consultant for Collegium Pharmaceutical, Nevro Corporation, Pain Scripts, Scilex Pharmaceuticals, Shiratronics, Tris Pharma, Vertex Pharmaceuticals, Vertamical, and Xgene Pharma; Investigator for Lundbeck, and Teva Pharmaceuticals; Stock Holder for Pfizer and Trevena.

Katherine Galluzzi, DO, CMD, FACOFP: Advisor for Eli Lilly

Pamela Kushner, MD, FAAFP (Moderator): Speaker for Janssen, Astellas, Bayer, Bausch/Salix

All others in control of content for this activity have disclosed no relevant financial relationships.

CME/CE Information

AMA PRA Category 1 Credits™

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308. 

 

Designation Statement

This activity is approved for 2.50 contact hour of continuing education, which includes 0.00 hours of pharmacology.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Instructions for Obtaining Credit

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer X out of the Y questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.

Supported by

Opioid Analgesic REMS Program Companies

Education Partner

Miller Medical Communications, LLC

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

Pain Management in Practice: Key Principles for Primary Care Providers

Register